MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer

Published:2019-06 Issue: Volume:303 Page:223-236
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Zamani Parvin,Navashenaq Jamshid Gholizadeh,Nikpoor Amin Reza,Hatamipour Mahdi,Oskuee Reza Kazemi,Badiee Ali,Jaafari Mahmoud Reza^ORCID

Funder

Mashhad University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference63 articles.

1. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead;Oiseth;J. Cancer Metastasis Treat.,2017

2. Cancer immunotherapy: the beginning of the end of cancer?;Farkona;BMC Med.,2016

3. Advances in strategies and methodologies in cancer immunotherapy;Lam;Discov. Med.,2015

4. Strategies for cancer vaccine development;Vergati;Biomed. Res. Int.,2010

5. Peptide delivery systems for cancer vaccines;He;Adv. Ther.,2018

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malaria transmission blocking activity of Anopheles stephensi alanyl aminopeptidase N antigen formulated with MPL, CpG, and QS21 adjuvants;PLOS ONE;2024-07-05

2. Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials;Journal of Controlled Release;2024-06

3. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine;Journal of Controlled Release;2024-05

4. In situ bio-mineralized Mn nanoadjuvant enhances anti-influenza immunity of recombinant virus-like particle vaccines;Journal of Controlled Release;2024-04

5. Peptide nanovaccine in melanoma immunotherapy;International Immunopharmacology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3